Where is Senti Bio headquartered?

Senti Bio is located in San Francisco, CA.

Who invested in Senti Bio?

Senti Bio has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Senti Bio?

Senti Bio closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

sentibio.com

Senti Bio

Senti Bio is a California-based biotechnology company that develops and commercializes cell-based therapeutics for the treatment of cancer.

Business Model:

Revenue: $0

Employees: 11-50

Geographic Data

Address: 329 Oyster Point Blvd

City: San Francisco

State: CA

Zip: 94080

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$51M

Raised Total:

$216M

Social

Twitter

Crunchbase

Metrics

4,439,673Website Global Rank

2,210Website Monthly Traffic

Twitter Followers

Description

Senti Bio is a California-based biotechnology company that develops and commercializes cell-based therapeutics for the treatment of cancer.

Contact Phone:
+16503823281

Contact Email:

IPO Details

Senti Bio went public on 6/9/2022 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/9/2022

IPO Valuation:
$601M

Ticker Symbol:
SNTI

Amount Raised:
$85M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
1/2021	Series B	21	$105M	Leaps by Bayer 10X Capital 8VC Alexandria Venture Investments Amgen Ventures Gaingels Intel Capital KB Investment Lifeforce Capital LifeSci Venture Partners Lux Capital Matrix Partners China Menlo Ventures Mirae Asset Capital Nest.Bio Ventures New Enterprise Associates Noveus Capital Pear VC Ridgeback Capital Sand Hill Angels Smilegate Investment Leaps by Bayer
6/2022	Post-IPO Equity		$0	8VC Amgen Ventures Invus Leaps by Bayer Morgan Stanley Investment Management NEA Parker Institute for Cancer Immunotherapy T. Rowe Price New Enterprise Associates 8VC Amgen Ventures Invus Leaps by Bayer Morgan Stanley Investment Management NEA Parker Institute for Cancer Immunotherapy T. Rowe Price New Enterprise Associates
12/2017	Grant	1	$225k	National Science Foundation National Science Foundation
9/2021	Grant	1	$1.9M	National Cancer Institute National Cancer Institute
5/2022	Convertible Note	1	$5.2M	Leaps by Bayer Leaps by Bayer
12/2016	Seed		$2M
6/2022	IPO SPAC		$296M
8/2020	Series A	2	-	GRIDS Capital Bossanova Investimentos GRIDS Capital Bossanova Investimentos
2/2018	Series A	12	$53M	New Enterprise Associates 8VC Allen &a; Company Amgen Ventures Evolution VC Partners Goodman Capital Lifeforce Capital Lux Capital Menlo Ventures Nest.Bio Ventures Omega Funds Pear VC New Enterprise Associates
6/2022	Post-IPO Equity	8	$50.6M	8VC Amgen Ventures Invus Leaps by Bayer Morgan Stanley Investment Management NEA Parker Institute for Cancer Immunotherapy T. Rowe Price 8VC Amgen Ventures Invus Leaps by Bayer Morgan Stanley Investment Management NEA Parker Institute for Cancer Immunotherapy T. Rowe Price
8/2020	Series A	2	-

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details